v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash flows from operating activities:    
Net Loss $ (1,025,807) $ (2,464,514)
Adjustments to reconcile net loss to cash used in operations:    
Depreciation 18,401 17,460
Amortization 47,513 47,513
Amortization of debt discount 9,900
Stock issued for services 8,512 84,000
Loss on conversion of notes payable 13,593
Gain on debt settlement (200,000)
Impairment expense on intangible asset 15,000
Impairment loss of Findex legacy software segment 1,433,465
Changes in operating assets and liabilities    
(Increase) decrease in accounts receivable (19,829) 36,701
(Increase) decrease in inventory (5,479) 31,162
Increase in other current assets (2,252) (3,109)
Increase in accounts payable and accrued expenses 311,334 327,744
Net cash used in operating activities (644,114) (674,578)
Cash flows from investing activities:    
Purchase of property and equipment (14,084)
Net cash used in investing activities (14,084)
Cash flows from financing activities:    
Proceeds from sale of common stock 71,000 465,000
Proceeds from issuance of convertible notes payable 10,000 250,000
Proceeds from issuance of convertible notes payable, related parties 735,000
Proceeds from sale of interest in variable interest entity 3,020
Payments made on notes payable (57,950) (37,500)
Net cash provided by financing activities 761,070 677,500
Net increase in cash and cash equivalents 102,872 2,922
Cash and cash equivalents, beginning of period 5,163 2,241
Cash and cash equivalents, end of period 108,035 5,163
Supplemental cash flow information:    
Interest paid 1,515 16,746
Cash paid for income taxes
Schedule of Non-Cash Investing and Financing Activities:    
Issuance of debt for loan modification 50,000
Issuance of notes payable for accrued directors fees 76,000
Issuance of notes payable for accrued base salary 483,933
Issuance of notes payable for accounts payable, related parties 94,700
Issuance of common stock for accrued directors fees 29,000
Issuance of common stock as consideration for note payable 10,456
Forgiveness of accounts payable to related party 8,754
Forgiveness of notes payable to related party $ 221,050